Artemis Medicare Services Q4 FY26 Earnings Call Recording Now Available Online

Artemis Medicare Services Limited has announced that the audio recording of its Earnings Conference Call for Q4 and FY26, held on May 11, 2026, is now available on the company's official website. The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was communicated via an official intimation signed by Poonam Makkar, Company Secretary and Compliance Officer.

Conference Call Details

The earnings call was hosted by Anand Rathi Research and focused on the operational and financial performance of the company for Q4 and FY26. The following table summarises the key details of the event:

Parameter:	Details
Event:	Q4 and FY26 Earnings Conference Call
Date:	Monday, May 11, 2026
Time:	11:00 AM IST
Hosted By:	Anand Rathi Research
Recording Available At:	Audio Recording Link

Key Participants

Senior leadership from Artemis Medicare Services was present on the call to address queries from investors and analysts:

Dr. Devlina Chakravarty — Managing Director
Mr. Sanjiv Kumar Kothari — Chief Financial Officer
Mr. Rudra Narayan Acharjee — Head – Investor Relations, M&A and Organization Growth Strategy

Access Details

Participants who wished to join the live conference call could do so through the following dial-in numbers:

Region:	Access Number
Universal Access:	022 6280 1386 / 022 7115 8287
USA:	+1 866 746 2133
UK:	0808 101 1573
Hong Kong:	800 964 448
Singapore:	800 101 2045

For further information, participants may contact the call co-ordinator, Himanshu Binani, at Office No: (022) 6626 6712 or Mobile: 7381039698. The audio recording of the call is now accessible on the Artemis Medicare Services website for investors and analysts seeking to review the discussion.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.37%	-2.21%	+11.50%	-4.47%	-2.06%	+905.37%

Artemis Medicare Services Limited has notified the stock exchanges of a change in its board composition, disclosing that Mr. Sunil Tandon has ceased to be a Director of the company. The development was communicated pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was filed by Company Secretary and Compliance Officer Poonam Makkar on May 10, 2026.

Board Change: Cessation of Independent Director

Mr. Sunil Tandon (DIN: 08342585) stepped down from the board of Artemis Medicare Services upon the completion of his tenure as an Independent Director on May 9, 2026. The cessation was a result of the natural expiry of his term and does not indicate any other circumstance. The company has disclosed the required details in accordance with Schedule III of the SEBI Listing Regulations.

Key Details of the Change

The following information has been provided by the company as required under Regulation 30 and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015:

Parameter:	Details
Name of Director:	Mr. Sunil Tandon
DIN:	08342585
Reason for Change:	Completion of tenure as Independent Director
Date of Cessation:	May 9, 2026
Brief Profile (Appointment):	Not Applicable
Disclosure of Relationships (Appointment):	Not Applicable

Regulatory Compliance

The intimation was submitted to both the National Stock Exchange of India Limited and BSE Limited in compliance with applicable listing regulations. The filing was signed and submitted by Poonam Makkar, Company Secretary and Compliance Officer of Artemis Medicare Services, on May 10, 2026. No further details regarding a replacement appointment were disclosed as part of this filing.